These findings hint at a potential role of IL4I1+ macrophages in DLBCL pathogenesis and offer the prospect of exploring the targeting of these cells, although additional mechanistic work will be required to confirm the feasibility of such putative therapeutic interventions. This evidence concerns the gene IL4I1 and diffuse large B-cell lymphoma.